With a market capitalization (market cap) of $2.21B — a measure of how much the company is worth — Establishment Labs Holdings Inc. is the 2034th most valuable company in Healthcare as of August 18, 2026. Shares trade at $75.22, down +1.83% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Visit websiteAs of August 18, 2026, Establishment Labs Holdings Inc. (ESTA) is worth $2.21B — this is its market capitalization, the total value of all its outstanding shares.
Establishment Labs Holdings Inc.’s market cap is $2.21B, which ranks it #2034 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Establishment Labs Holdings Inc. (ESTA) shares trade at $75.22, down 1.83% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025